Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
7rh is an inhibitor of discoidin domain receptor 1 (DDR1; IC50 = 6.8 nM).1 It is selective for DDR1 over DDR2, Bcr-Abl, and c-Kit (IC50s = 101.4, 355, and >10,000 nM, respectively). 7rh inhibits the proliferation of A549, H23, and H460 non-small cell lung cancer (NSCLC) and K562 leukemia cells (IC50s = 2.7, 2.1, 3, and 0.038 µM, respectively). It also inhibits the invasion and cell-matrix adhesion of H23 cells when used at a concentration of 5 µM. 7rh (8 mg/kg) reduces tumor volume in a CNE-2 nasopharyngeal carcinoma mouse xenograft model when administered alone or in combination with dasatinib (Item No. 11498).2
WARNING This product is not for human or veterinary use.
1. Discovery and optimization of 3-
2. Antitumor activity of 7RH, a discoidin domain receptor 1 inhibitor, alone or in combination with dasatinib exhibits antitumor effects in nasopharyngeal carcinoma cells. Oncol. Lett. 12(5), 3598-3608 (2016).